Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA

Abstract

We report three pediatric patients with ganciclovir-resistant cytomegalovirus (CMV) retinitis who were successfully treated with foscarnet. The patients were recipients of hematopoietic stem cell transplantation (SCT) from HLA-mismatched donors. Because these patients had developed or experienced progressive CMV retinitis during ganciclovir therapy, they received foscarnet therapy at 60 mg/kg every 8 h. Their retinitis resolved promptly after initiating foscarnet therapy, suggesting foscarnet's effectiveness in treating ganciclovir-resistant CMV infection. The amount of CMV mRNA was quantitatively measured using an NASBA technique, which amplified the β2.7 transcripts specific for CMV replication. This technique was useful for monitoring disease activity in a more rapid and sensitive manner than the PCR assay for CMV DNA. Bone Marrow Transplantation (2001) 27, 1141–1145.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Erice A, Chou S, Biron KK et al. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients New Engl J Med 1989 320: 289–293

    Article  CAS  PubMed  Google Scholar 

  2. Jacobson MA, Drew WL, Feinberg J et al. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS J Infect Dis 1991 163: 1348–1351

    Article  CAS  PubMed  Google Scholar 

  3. Drobyski WR, Knox KK, Carrigan DR, Ash RC . Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation Transplantation 1991 52: 155–157

    Article  CAS  PubMed  Google Scholar 

  4. Dieterich DT, Poles MA, Dicker M et al. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction Am J Gastroenterol 1993 88: 542–548

    CAS  PubMed  Google Scholar 

  5. Balfour HH Jr . Antiviral drugs New Engl J Med 1999 340: 1255–1268

    Article  PubMed  Google Scholar 

  6. Drew WL . Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance J Acquir Immune Defic Syndr 1991 4: (Suppl. 1) S42–46

    PubMed  Google Scholar 

  7. Kievits T, van Gemen B, van Strijp D et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection J Virol Meth 1991 35: 273–286

    Article  CAS  Google Scholar 

  8. Aono T, Kondo K, Miyoshi H et al. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification J Infect Dis 1998 178: 1244–1249

    Article  CAS  PubMed  Google Scholar 

  9. Gerna G, Baldanti F, Lilleri D et al. Human cytomegalovirus immediate–early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients J Clin Microbiol 2000 38: 1845–1853

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Kondo K, Xu J, Mocarski ES . Human cytomegalovirus latent gene expression in granulocyte–macrophage progenitors in culture and in seropositive individuals Proc Natl Acad Sci USA 1996 93: 11137–11142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Miyoshi H, Tanaka-Taya K, Nagae Y et al. Cytomegalovirus retinitis after transplantation of positively selected CD34+ cells from HLA-mismatched donors Pediatr Infect Dis J 1998 17: 345–348

    Article  CAS  PubMed  Google Scholar 

  12. Chou S, Marousek G, Guentzel S et al. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease J Infect Dis 1997 176: 786–789

    Article  CAS  PubMed  Google Scholar 

  13. Pérez JL . Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance Microbiologia 1997 13: 343–352

    PubMed  Google Scholar 

  14. Jacobson MA, Kramer F, Bassiakos Y et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151 J Infect Dis 1994 170: 189–193

    Article  CAS  PubMed  Google Scholar 

  15. Walton RC, Whitcup SM, Mueller BU et al. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis Ophthalmology 1995 102: 1865–1870

    Article  CAS  PubMed  Google Scholar 

  16. Bacigalupo A, Bregante S, Tedone E et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation Transplantation 1996 62: 376–380

    Article  CAS  PubMed  Google Scholar 

  17. Manfredi R, Mastroianni A, Coronado OV, Chiodo F . The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports Recent Prog Med 1996 87: 545–548

    CAS  Google Scholar 

  18. Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation Br J Haematol 1994 86: 130–137

    Article  CAS  PubMed  Google Scholar 

  19. Hebart H, Müller C, Löffler J et al. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation Bone Marrow Transplant 1996 17: 861–868

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohta, H., Matsuda, Y., Tokimasa, S. et al. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA. Bone Marrow Transplant 27, 1141–1145 (2001). https://doi.org/10.1038/sj.bmt.1703055

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703055

Keywords

This article is cited by

Search

Quick links